The requirements for pharmaceutical supply chains in Europe continue to increase. Growing regulatory requirements, more complex supply chains, and rising expectations regarding transparency and supply security are shaping the market. At the same time, demand for specialized and customized logistics solutions is increasing, making integrated and resilient networks more important than ever.

VITAIRA Strengthens Its European Network Through a Targeted Acquisition
VITAIRA’s strategy is based on acquiring complementary logistics and freight forwarding companies to build an integrated European pharmaceutical logistics group.
With Hommel Pharma, VITAIRA has already established a key cornerstone in temperature-controlled pharmaceutical logistics, serving as the network’s Western Hub. Through the acquisition of SCHNEIDER+PEKLAR, VITAIRA strategically expands its expertise in freight forwarding and international transportation solutions while strengthening its coverage across the DACH region and beyond.

The acquisition offers several strategic advantages for VITAIRA:

• Expansion of pharmaceutical logistics expertise through GDP- and TAPA-certified cold chain solutions and extensive know-how in regulated transportation
• Access to an established international network focused on Europe, with connections to Central and Eastern Europe (CEE) and neighboring markets
• Diversified and well-established customer base with longstanding relationships in the pharmaceutical and healthcare sectors
• Scalable platform for future growth in freight forwarding and value-added services
• High operational quality based on certified processes and extensive experience in managing complex and time-critical logistics solutions

Specialized Freight Forwarding and Logistics Expertise

SCHNEIDER+PEKLAR is a specialized provider of freight forwarding and logistics solutions with a focus on road and air freight, complemented by sea and rail transportation services. The company offers an integrated range of services across the supply chain, including:

• International transportation management (FTL, LTL, air freight)
• GDP-compliant, temperature-controlled warehousing and cross-docking solutions
• Customs clearance and documentation management
• Dangerous goods logistics (ADR, IATA-DGR, IMDG)
• Time-critical special and project logistics
• In addition, the company possesses extensive expertise in handling complex and critical logistics scenarios as well as international specialty transportation projects.

Strategic Vienna Location to Serve as Southern Hub with Access to CEE Markets
Key advantages of the Vienna location include:

• Direct access to Vienna International Airport, including immediate proximity to the runway
• Strategic gateway to Central and Eastern Europe (CEE) and connections toward Central Asia

Executive Perspectives
“With SCHNEIDER+PEKLAR, we are gaining a partner that is a highly specialized provider of freight forwarding and logistics solutions across complex transportation chains. With its headquarters in Vienna and a branch office in Bratislava, Slovakia, we are strengthening our presence in the DACH region while creating a strategic connection to Central and Eastern Europe (CEE) as well as routes toward Central Asia – a significant milestone in building our European temperature-controlled specialty logistics group.” Andreas Thiede, CEO & Founder, VITAIRA

“Together with VITAIRA, we are creating a strong network with a clear geographic structure. Our location at Vienna Airport perfectly complements Hommel Pharma’s existing Western Hub and significantly enhances access to Central and Eastern Europe – a decisive step toward building a comprehensive European pharmaceutical logistics platform.”
Valentin Peklar, Managing Director, SCHNEIDER+PEKLAR

About VITAIRA
Founded in August 2025, VITAIRA is building a European network of specialized pharmaceutical logistics and transport companies through the acquisition of complementary logistics and transportation businesses. Its mission is to consolidate temperature-controlled pharmaceutical and healthcare services across regulated supply chains on a single platform from GDP-compliant transportation and warehousing solutions to GMP-certified value-added services. The company is led by CEO and Founder Andreas Thiede.
For more information, visit www.vitaira-group.com.

About SCHNEIDER+PEKLAR
SCHNEIDER+PEKLAR Speditions-Partner GmbH is an internationally active logistics and freight forwarding provider headquartered at Vienna International Airport.
The company has particular expertise in pharmaceutical logistics and supports customers with secure, quality-assured transportation and logistics solutions across regulated supply chains. In addition to pharmaceutical transportation and high-value goods logistics, its core services include international groupage transport, direct shipments, and tailored logistics solutions.
SCHNEIDER+PEKLAR combines decades of experience in European transportation with personalized customer service, high service quality, and digitally supported processes. Through certifications such as ISO 9001, GDP, TAPA, and IFS, the company meets the highest standards of quality and security.

The post VITAIRA ENTERS AUSTRIA THROUGH THEACQUISITION OF SCHNEIDER+PEKLAR appeared first on Greenpeak Partners.

AXAITRA, a Microsoft Frontier Partner — Microsoft’s most advanced partner designation — today announced a partnership with Pax8, the global AI and cloud Marketplace for small and medium-sized businesses (SMBs), to accelerate the adoption of outcome-driven Microsoft AI solutions across Europe.

The announcement builds on AXAITRA’s recognition as a Microsoft Frontier Partner on July 1, validating the company’s vision of transforming Microsoft’s latest AI innovations into standardized, governed and commercially packaged service offerings that deliver measurable business outcomes.

The AI market is entering a new phase. Organizations no longer invest in AI for technology’s sake — they expect measurable improvements in productivity, business process automation, employee experience, security and competitive advantage. AXAITRA was built around exactly this principle.

As Europe’s AI Agent Factory, AXAITRA industrializes Microsoft AI by transforming technologies such as Microsoft 365 Copilot, AI Agents, AI Governance, Security and Frontier Transformation into repeatable, business-ready service offerings. Rather than delivering one-off consulting projects, AXAITRA continuously designs, validates, packages and evolves standardized offerings that enable customers to adopt AI faster, reduce implementation risk and achieve predictable business value.

As a new Pax8 partner, AXAITRA is creating a scalable go-to-market model that extends these outcome-driven offerings across Europe. By combining AXAITRA’s AI Factory approach with Pax8’s AI and cloud Marketplace and partner ecosystem, customers gain faster access to proven Microsoft AI solutions while benefiting from consistent delivery, enterprise-grade governance and measurable results.

The initial portfolio available through this collaboration includes packaged offerings covering Microsoft 365 Copilot, AI Agents, AI Governance, AI Security and Frontier Transformation, enabling organizations to move from isolated AI pilots toward enterprise-wide AI adoption with confidence.

Werner Leibrandt, COO / VP Operations, AXAITRA, said:

“Customers buy outcomes, not technologies. Achieving Microsoft Frontier Partner status validates our strategy of industrializing AI. Together with Pax8, we are creating a scalable go-to-market model for Europe’s AI Agent Factory — bringing standardized, outcome-driven Microsoft AI service offerings to customers across Europe through the AXAITRA ecosystem.

Our mission is simple: make enterprise-grade AI easier to buy, faster to deploy and measurable in business impact. Whether customers are adopting Microsoft 365 Copilot, building AI Agents, establishing AI Governance or driving Frontier Transformation, they should be able to consume proven solutions that deliver business value — not just technology.”

Harald Nuij, EMEA CEO at Pax8, said:

“Pax8 is committed to helping partners deliver greater value to their small and medium sized businesses they serve through innovation and simplicity. AXAITRA brings a unique capability to transform Microsoft’s AI technologies into repeatable business solutions. Together, we will help accelerate AI adoption across Europe by making enterprise-grade Microsoft AI easier to access, deploy and scale.”

The partnership reinforces a shared commitment to accelerating Microsoft’s AI vision across Europe. By combining industrialized AI service offerings with a scalable AI and cloud Marketplace, AXAITRA and Pax8 are enabling organizations to move beyond experimentation and realize measurable business outcomes faster.

About AXAITRA 

AXAITRA is Europe’s AI Agent Factory and a Microsoft Frontier Partner. The company industrializes Microsoft AI by transforming Microsoft 365 Copilot, AI Agents, AI Governance, Security and Frontier Transformation into standardized, governed and commercially packaged service offerings. Through its ecosystem of specialized companies and strategic alliances, AXAITRA enables organizations across Europe to accelerate AI adoption and achieve measurable business outcomes with predictable delivery and enterprise-grade governance.

The post AXAITRA Selects Pax8 as Strategic Marketplace to Scale Europe’s AI Agent Factory appeared first on Greenpeak Partners.

This partnership brings together AXAITRA’s strong Cloud and Microsoft AI focus with Comitas’s deep track record in custom software development, Azure solutions, and digital transformation for Swiss SMEs and public sector organisations. Comitas’s rigorous approach to compliance and governance — backed by ISO 27001 certification and the CyberSeal label — becomes an important pillar of AXAITRA’s knowledge and innovation ecosystem, giving partner companies and customers a trusted foundation to adopt AI technologies faster and more securely, particularly in regulated industries and the public sector.

“We were looking for a partner that wouldn’t slow our ambitions down, but accelerate them,” said André Brühlmann, Co-Founder and Chairman of the Board of Comitas AG. “With AXAITRA, we gain access to technology, expertise, and a network that is actively shaping AI transformation across Europe. For our team, this is a real step forward — and for our customers, the trusted point of contact they know stays exactly the same, now with new possibilities alongside it.”

Founded in 2000, Comitas has built two and a half decades of experience delivering custom software and Azure applications, guiding Swiss SMEs and public institutions through digital transformation. As part of the AXAITRA Group, Comitas now combines that experience with a strong Cloud and Microsoft AI focus, taking a decisive step into Agentic AI.

Within AXAITRA, Comitas will continue to operate independently while contributing to the group’s vision and mission: building Europe’s most advanced Microsoft-centric platform for AI-powered solutions.

“Comitas brings real substance to this partnership,” said Robert Helgerth, CEO of the AXAITRA Group. “An experienced team, long-standing customer relationships, and an uncompromising standard for security and governance. That’s exactly the foundation we need to translate AI agents into measurable value in regulated environments. Together, we’re building Europe’s leading Microsoft AI partner network — and Comitas is an ideal building block for that.”

About Comitas AG

Comitas AG is a Swiss software and Azure solutions provider founded in 2000, helping SMEs and public institutions navigate digital transformation with a strong focus on compliance and governance, certified to ISO 27001 and CyberSeal standards.

For more information, visit www.comitas.ch.

About AXAITRA

AXAITRA is a leading European platform for cloud and AI services, specialising in Microsoft technologies. Together with Greenpeak Partners, AXAITRA is building the partner network of the future for Microsoft and continuously integrates innovative companies that strategically complement its portfolio.

The post Comitas AG Joins AXAITRA Group to Expand Governed AI Adoption Across Europe appeared first on Greenpeak Partners.

Etanomics supports companies in the energy transformation of existing operational and real estate assets – from analyzing and developing CO₂ reduction strategies and energy concepts to implementation, commissioning, and operational performance monitoring. A particular focus lies on aligning technical measures with economic objectives and regulatory requirements.

Headquartered in Neu-Isenburg near Frankfurt am Main, Etanomics has extensive experience delivering complex industrial and specialized projects, particularly in the pharmaceutical, manufacturing, and energy infrastructure sectors.

“With Etanomics, we are welcoming a partner that combines deep technical expertise with a clear understanding of operational and economic realities,” says Dr. Rico Pires, CEO of encoviva. “The transformation of existing buildings and industrial facilities requires an integrated approach that considers energy, operations, and investment decisions simultaneously. Etanomics brings exactly this perspective to our partnership, reinforcing our commitment to delivering holistic, long-term value for our clients.”

“Etanomics was founded on the conviction that energy efficiency and decarbonization are not merely environmental challenges but key drivers of competitiveness, long-term resilience, and cost reduction,” says Dr.-Ing. Timm Rössel, Managing Director of Etanomics. “As part of the encoviva partnership, we can combine technical excellence, commercial thinking, and implementation expertise to make sustainable transformation practical, predictable, and economically viable for our clients.”

Etanomics’ service portfolio includes transformation roadmaps for CO₂ reduction, energy audits, district heating feasibility studies, energy management systems, as well as commissioning and performance optimization of technical installations. These capabilities complement the existing expertise within the encoviva partnership, particularly in the areas of operational implementation and the sustainable operation of technical assets.

The addition of Etanomics further underlines encoviva’s strategic vision of bringing together specialized companies with clearly defined areas of expertise into a high-performing partnership. The goal is to provide integrated support for construction, real estate, and industrial projects throughout their entire lifecycle – from concept development through to operation.

About Etanomics

Etanomics is a specialized engineering and consulting company focused on energy efficiency, decarbonization, and the sustainable transformation of buildings and industrial facilities. The company supports clients from the initial analysis and development of tailored solutions through implementation and the operation of optimized energy systems.

About encoviva

encoviva is a partnership of independent, specialized companies operating in planning, engineering, consulting, and project management. Its mission is to combine interdisciplinary expertise to deliver construction and real estate projects that are economically sound, technically precise, and designed to create lasting value.

The post Etanomics joins the encoviva Partnership appeared first on Greenpeak Partners.

Horiana brings deep French RWE expertise across epidemiology, biostatistics, advanced methods on primary and secondary data studies. Its mastery of the nationwide French health data sources, including SNDS and PMSI, gives athagoras direct access to one of Europe’s richest and most consequential healthcare datasets, complementing the Group’s established capabilities in Nordic registries and strengthening its ability to generate robust, submission-ready evidence.

By combining Horiana’s French RWE depth with the Group’s existing capabilities in market access, regulatory affairs, and technology, athagoras is now positioned to support pharmaceutical and biotech clients from evidence strategy through JCA, payer engagement, and national reimbursement without handoffs, and with genuine local expertise in every market that matters.

“Horiana is a major addition to our RWE platform,” said Giuseppe Pileggi, CEO of athagoras. “The team brings the scientific depth and data expertise needed to answer increasingly complex evidence questions for healthcare decision-making. With privileged access to Nordic registries and the French national health data system, now both within the Group, we can deliver the kind of pan-European evidence that JCA and national payers increasingly require with boutique rigor at every step.”

Céline Fabre, CEO of Horiana, added: “Joining athagoras is a natural next step for Horiana. We share the same culture and the same ambition to deliver innovative and trusted evidence. This combination allows us to bring our French RWE and methodological expertise into a broader European platform, while continuing to serve clients with the scientific standards and entrepreneurial approach that define who we are.”

Kirk Geale, Head of athagoras RWE, commented that “Horiana’s French RWE expertise is highly complementary to athagoras’ established strengths in the Nordics, Germany, and UK. Together, we can help clients navigate Europe’s diverse health data and create robust, fit-for-purpose evidence for regulatory, clinical, and commercial decision-making.”

athagoras is building the specialist European partner for evidence and access combining boutique expertise, scientific excellence, and coordinated execution across every market that matters. Your Gateway to Europe®

The post A new chapter in France: athagoras welcomes Horiana appeared first on Greenpeak Partners.

The formation of the Supervisory Board underscores GREENPEAK’s long-term commitment to robust corporate governance, clear oversight structures, and sustainable value creation. As GREENPEAK continues to expand its investment activities and strategic footprint, the Supervisory Board will serve as an independent and experienced body to supervise management, provide strategic guidance, and support the further development of the firm in line with best-practice governance standards.

With a carefully selected composition of highly experienced leaders from the fields of corporate governance, strategy, capital markets, and international growth investing, the Supervisory Board brings together complementary expertise that will actively accompany GREENPEAK’s next phase of development.

The Supervisory Board is composed of four members:

Chairman of the Supervisory Board
🔹 Philipp Ostermeier

Philipp Ostermeier brings more than 25 years of experience in strategic and financial advisory for listed companies and German family businesses. He contributes a unique combination in transformation and corporate governance. His career includes roles at Arthur Andersen and Ernst & Young, over a decade as Partner at KPMG, and his current position as Managing Director at Alvarez & Marsal Germany. He has also been admitted to the Munich Higher Regional Court since 2006.

Member of the Supervisory Board
🔹 Jörn Nikolay

Jörn Nikolay contributes extensive international investment and strategy experience. He spent more than 16 years at General Atlantic, including over a decade leading the DACH region, and was involved in more than ten equity investments totaling approximately EUR 3 billion. His previous roles at TA Associates, Bain & Company, and Morgan Stanley further underline his deep expertise in growth investing and strategic execution.

Member of the Supervisory Board
🔹 Dr. Bettina Mittermeier

Dr. Bettina Mittermeier brings deep expertise in supervisory board work, corporate governance, and capital markets. She currently is a member of the Supervisory Board of Clearvise AG and of the Advisory Board of de Haen-Carstanjen & Söhne KG. She also served as Chair of the Supervisory Board of Tion Renewables AG for several years. Previously, she spent more than ten years as (Senior) Legal Counsel at Allianz SE, advising both the Executive Board and Supervisory Board on corporate law, governance, remuneration, and regulatory matters. She began her legal career at the international law firm Milbank LLP after completing her doctorate at the Max Planck Institute in Hamburg.

Member of the Supervisory Board
🔹 Florian Kopp

Florian Kopp brings more than 25 years of experience in corporate leadership, strategy development, and investment management. In addition to serving as Managing Director of several mid-market business groups, he has extensive expertise in buy-and-build strategies, M&A transactions, and the development of growth-oriented platforms. Having led GREENPEAK’s Portfolio Management function from 2020 to 2025 and served as Managing Director of several GREENPEAK entities, he contributes deep knowledge of the firm’s platform and strategic development. He also brings significant experience from various board and supervisory positions.

“The establishment of our Supervisory Board marks an important milestone in GREENPEAK’s continued development. With Philipp Ostermeier, Jörn Nikolay, Dr. Bettina Mittermeier, and Florian Kopp, we have brought together exceptional expertise in governance, strategy, and growth investing. I am looking forward to working closely with the Board and am confident that their experience and guidance will be instrumental in supporting GREENPEAK’s next phase of growth.”, says Daniel Beringer, CEO & Managing Partner, GREENPEAK Partners.

Alongside the establishment of the Supervisory Board, GREENPEAK has refined its management structure. GREENPEAK Management GmbH is divided into Portfolio Management, led by Daniel Beringer and Philipp Meyer, and Risk Management, headed by Oliver Frank and Dr. Julia Keim.

About GREENPEAK Partners

GREENPEAK Partners, headquartered in Munich, is an investment firm specialising in building and scaling mid-market business groups with a strong track record. The company has extensive experience in founding, developing and expanding market leaders. As part of its develop-buy-and-build strategies, GREENPEAK aims to establish market-leading platforms as integrated partnerships for all stakeholders – with aligned, sustainable interests and ambitious ESG principles. To date, the GREENPEAK team has built more than 15 platforms generating over €1 billion in annual revenue.
More information at www.greenpeak-partners.com.

The post GREENPEAK Partners has established a Supervisory Board to support continued growth and governance excellence appeared first on Greenpeak Partners.

Munich | London, UK | 18 June 2026 – SPGL joins CERTANIA. Quality Assurance Specialist expands CERTANIA’s Life Sciences offering across Europe. The company is a leading provider of CQV (Commissioning, Qualification, Validation) and GxP Quality Assurance & Compliance services. They support pharmaceutical and biotechnology manufacturers with their qualification and validation needs, creating certainty for our clients and ultimately helping to improve patient safety.

Headquartered in London, SPGL operates an additional execution office in Antwerp, Belgium, with delivery capacity across multiple European markets. The company primarily supports multinational pharmaceutical and biotechnology manufacturers with GxP regulated facilities across Europe. Clients include companies such as Johnson & Johnson, Sanofi and Pfizer. 

“With SPGL, we are expanding our life sciences activities in a critical area: GxP quality assurance and compliance for biopharmaceutical manufacturers. SPGL will serve as our Centre of Excellence for CQV and Quality Assurance & Compliance, featuring a multi-country delivery structure and the ability to consistently support clients throughout commissioning, qualification, validation and ongoing compliance,” says Karsten Xander, CEO of CERTANIA. 

“Our strength has always been the ability to manage quality and improve performance for our clients. Joining CERTANIA gives us the scale, reach and resources to accelerate our growth across Europe while maintaining the technical excellence and customer focus that define SPGL,” says Jay Lad, Executive Director of SPGL. 

The partnership significantly strengthens CERTANIA’s capabilities in Testing, Inspection and Compliance regulated industries and establishes a dedicated European Centre of Excellence for quality assurance, compliance, qualification and validation services. 

About CERTANIA: 
CERTANIA Group, headquartered in Munich, is an internationally active Testing, Inspection, Certification & Compliance company with decades of experience. Its experts shape industry standards and continuously advance methods across life sciences, food and consumer goods, industrials, buildings and infrastructure, as well as certification and compliance. More information: www.certania.com. 

About SPGL Limited:  
SPGL is a specialist consulting group comprising of two dedicated divisions: GMP & Technical Services and QACC (Quality Assurance Consulting & Compliance).  
GMP & Technical Services supports organisations operating in GMP regulated environments across Biopharmaceuticals, Medical Devices & Diagnostics, Healthcare, Regulated Consumer Products, Chemicals, and Mission Critical Facilities. The division provides Commissioning, Qualification, Validation, Quality Assurance, Auditing, Training and Regulatory Compliance services throughout Europe.  
QACC delivers specialist quality assurance, auditing and compliance consultancy services to GxP regulated organisations across the EMEA region. Its expertise spans GCP, GVP, CSV, and GxLP disciplines, supporting clients throughout the product lifecycle with mock inspections, due diligence assessments, QMS consultancy, gap analyses and regulatory readiness programmes. SPGL is headquartered in London and operates an additional delivery office in Antwerp, Belgium. More information: www.spgl.eu. 

The post SPGL joins CERTANIA – Expanding European Pharma CQV & Quality Assurance appeared first on Greenpeak Partners.

Munich | Delft | 9th June 2026 – Van Santen Advies has joined the CERTANIA Group. In the Netherlands, Van Santen supports property owners, housing associations and developers with hazardous material compliance and risk assessments – particularly in the context of asbestos and other regulated substances – and provides robust documentation aligned with legal requirements. 

Founded in 2013, Van Santen comprises Van Santen Advies B.V., Van Santen Projecten B.V. and Van Santen Inspectie B.V. Its operating model is structured around three pillars: Advisory (e.g., asbestos, chromium–6), Project Management (e.g., remediation and demolition projects) and Inspection (e.g., moisture, mould, leak detection and drying technology). This enables end–to–end support for customers – from assessment and planning through execution, verification and documentation. 

As part of the integration, Van Santen will work closely with SGI Compliance, another CERTANIA company. The objective is a coordinated service offering for customers in the Netherlands covering hazardous material compliance and building inspections – from planning through to documentation. 

“As a globally active TIC provider, CERTANIA continuously develops its service portfolio. With Van Santen, we expand our coverage in the Netherlands within Buildings & Infrastructure across hazardous material compliance and building inspections – with the clear goal of supporting customers reliably across disciplines,” said Moritz Gruber, CEO of CERTANIA. 

“When hazardous materials are involved in existing buildings, customers need quick clarity and clean, robust documentation,” said Cock van Santen, Managing Director of Van Santen Advies. “Together with CERTANIA, we can deliver this consistently nationwide – especially for housing associations and public–sector clients.” 

“We complement hazardous material compliance with recurring building inspections – such as moisture, mould and leak detection,” added Mark Verbrugge, Managing Director of Van Santen Advies. “This helps customers obtain a complete picture faster for sound decisions across their building portfolio.” 

About CERTANIA: 
CERTANIA Group, headquartered in Munich, is an internationally active Testing, Inspection, Certification & Compliance company with decades of experience. Its experts shape industry standards and continuously advance methods across life sciences, food and consumer goods, industrials, buildings and infrastructure, as well as certification and compliance. More information: www.certania.com. 

About Van Santen: 
Van Santen is a Dutch specialist in asbestos and hazardous material compliance and building inspections, headquartered in Delft, the Netherlands. Founded in 2013, the Van Santen group comprises Van Santen Advies B.V., Van Santen Projecten B.V. and Van Santen Inspectie B.V., providing services across three pillars: Advisory, Project Management, and Inspection (including moisture, mould and leak detection). More information: www.vs–advies.nl.  

The post Van Santen Advies joins the CERTANIA Group  appeared first on Greenpeak Partners.

Munich | Edinburgh, United Kingdom | 7^th May 2026 – With this addition, the CERTANIA Group – now comprising nearly 50 companies – continues its growth trajectory and expands its Industrials service segment with additional expertise in Regulatory Science and Chemical Compliance, with a clear focus on EU and UK regulation. 

Blue Frog Scientific Group Limited (“Blue Frog Scientific”) joins the CERTANIA Group and strengthens the Industrials segment with additional capabilities in Regulatory Science and Regulatory Affairs. Founded in 2010, the company is headquartered in Edinburgh and has a presence in the United Kingdom as well as in France (Lyon). 

Blue Frog Scientific supports large and mid-sized companies in the chemical, plant protection including biopesticide, biocide and pharmaceutical sectors – often within consortia – with EU and UK compliance activities. Its service scope includes dossier preparation, risk assessments, advocacy services, ongoing regulatory maintenance, and strategic advisory. Blue Frog Scientific also adds scientific depth in toxicology and human health assessment, ecotoxicology and environmental health, environmental fate and behaviour, chemistry, endocrine disruption, new approach methodologies (NAMs), environmental modelling, efficacy, and metabolism, supporting complex dossiers across multiple regulatory cycles. 

With Blue Frog Scientific joining CERTANIA, the Group strengthens its footprint in the United Kingdom and extends its operational reach in France. Together with CS Regulatory Services and Mediator, this creates broader EU/UK coverage in chemical compliance – providing a basis for multi-country mandates and cross-selling across the Group’s compliance offering. 

“As a globally active TIC provider, the CERTANIA Group continuously develops its service portfolio. With Blue Frog Scientific, we are strengthening our Regulatory Science and Chemical Compliance capabilities within the Industrials segment – particularly for EU and UK requirements,” says Karsten Xander, CEO of the CERTANIA Group. 

“Blue Frog Scientific strengthens the Group with leading expertise in regulatory affairs, human safety, environmental safety, chemistry, and new approach methodologies, underpinning the delivery of cutting-edge data sets, risk assessments, and long-term stewardship of complex regulatory dossiers,” says Dr. Damien Carson, Founder and CEO, Blue Frog Scientific. 

“For our clients, delivery is what matters; from regulatory strategy and data generation through to dossier preparation, submission and ongoing compliance. Within the CERTANIA Group, we can now increase our capacity and take on larger projects across a broader range of jurisdictions, while maintaining the high-quality service we’re known for,” adds Tom Hargreaves, Founder and CEO, Blue Frog Scientific. 

About Blue Frog Scientific 

Blue Frog Scientific is a UK- and France-based scientific and regulatory affairs consultancy supporting EU and UK regulatory compliance across chemicals, biocides, plant protection products including biopesticides, and pharmaceuticals. The firm provides strategic consultancy, dossier preparation, risk assessments and advocacy services, supporting registrations and ongoing compliance. More information: www.bluefrogscientific.com. 

About CERTANIA 

CERTANIA Group, headquartered in Munich, is an internationally active Testing, Inspection & Certification (TIC) company with centuries of combined experience. Its experts shape industry standards and continuously advance methods across life sciences, food and consumer goods, industrials, buildings and infrastructure, as well as certification and compliance. More information: www.certania.com. 

The post Blue Frog Scientific joins CERTANIA  appeared first on Greenpeak Partners.

Based in Preetz, Schleswig-Holstein, ICP Analytik has more than 25 years of experience in water analytics. The company is accredited in accordance with DIN EN ISO/IEC 17025 and listed as a drinking water testing body in Schleswig-Holstein. Its service portfolio includes drinking water testing, including Legionella analysis and services related to the German Drinking Water Ordinance, environmental analytics covering areas such as air, soil, swimming and bathing water, and wastewater, as well as market-leading sampler training programmes. 

With ICP Analytik, CERTANIA strengthens its presence in Northern Germany and expands its ability to coordinate sampling and analytics efficiently. A key element is ICP Analytik’s proprietary digital infrastructure, UMPO/LIMS, which digitally maps workflows from order entry and sampling through to laboratory analysis, reporting, and invoicing. In addition, ICP Analytik brings a nationwide network of external samplers, supporting broader reach and responsiveness in the market. 

The integration also creates concrete synergy potential within the Group. By connecting ICP Analytik with CERTANIA partners in water and environmental analytics, CERTANIA can bundle expertise and support customers with a broader, complementary service offering. 

“ICP Analytik is a strong technical addition to our Buildings & Infrastructure segment,” says Karsten Xander, CEO of the CERTANIA Group. “The company contributes accredited drinking water and environmental analytics, a nationwide sampling network, and a digital process platform. This strengthens our ability to scale analytical services efficiently and support customers with robust documentation along regulatory requirements.” 

“For our customers, it is critical that sampling, analytics, and documentation work together reliably,” says Dr Ulf Krause, Managing Director of ICP Analytik. “With CERTANIA, we gain access to complementary capabilities within a wider laboratory network and can continue to develop our service coverage in Northern Germany and beyond in a targeted way.” 

“Our strength lies in digitally supported workflows and a scalable model, from order entry through to the provision of results,” adds Dr Peter Brückner, Managing Director of ICP Analytik. “Within the Group, we can further develop this infrastructure and shape collaboration with partners in a way that enables customers to be supported faster, more consistently, and with audit-ready documentation.” 

About CERTANIA 

CERTANIA Group, headquartered in Munich, is an internationally active Testing, Inspection & Certification (TIC) company with centuries of combined experience. Its experts shape industry standards and continuously advance methods across life sciences, food and consumer goods, industrials, buildings and infrastructure, as well as certification and compliance. More information: www.certania.com. 

About ICP Analytik 

ICP Analytik GmbH & Co. KG is an accredited analytical laboratory based in Preetz, Schleswig-Holstein. The company provides drinking water and environmental analytics, as well as sampling and training services for customers in regulated application areas. More information: www.icp-analytik.de. 

The post ICP Analytik joins Certania, expanding water and environmental analytics coverage appeared first on Greenpeak Partners.